Excellerant, Inc. (EXCL) Stock

About Excellerant, Inc.

Excellerant, Inc. is an emerging firm that offers diverse health-related consultation and travel coordination services to both corporate clients and private individuals. Its planned offerings encompass advisory services covering conventional and complementary medical practices, alongside advanced medical technologies. Furthermore, it aims to assist clients in selecting suitable treatment facilities, crafting detailed travel plans that incorporate clinics, hospitals, and other healthcare centers, and supplying guidance for prospective customers. The company also furnishes essential information regarding transportation logistics and healthcare providers. Established in 2019, this Brussels, Belgium-based entity operates as a subsidiary of Swamson Capital AG.

Excellerant, Inc. (EXCL) stock trades at $0.00 with a market capitalization of $1130. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.03, reflecting a net loss over the last twelve months, a negative price-to-book of -0.06, reflecting negative shareholders' equity, price-to-sales of 0.00.

On profitability, Excellerant, Inc. generates a return on equity (ROE) of 106.26% (not meaningful, as shareholders' equity is negative), return on capital employed of 69.39%.

Official website: excellerant.vc